Harbour Investments, Inc. Trevena Inc Transaction History

Harbour Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.5 $14,500 - $36,250	72,500 Added 145.0%	122,500 $51,000
Q4 2021 Feb 16, 2022	SELL	$0.57 - $1.29 $153,343 - $347,039	-269,023 Reduced 84.33%	50,000 $29,000
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $27,750 - $42,500	25,000 Added 8.5%	319,023 $392,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $11,471 - $17,678	7,857 Added 2.75%	294,023 $497,000
Q1 2021 Aug 17, 2021	BUY	$1.77 - $2.93 $494,477 - $818,542	279,366 Added 4108.32%	286,166 $512,000
Q1 2021 May 12, 2021	BUY	$1.77 - $2.93 $12,036 - $19,924	6,800 New	6,800 $12,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.